AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 290: R1087-R1093, 2006. First published November 23, 2005; doi:10.1152/ajpregu.00446.2005
0363-6119/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/4/R1087    most recent
00446.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Serrador, J. M.
Right arrow Articles by Gelb, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Serrador, J. M.
Right arrow Articles by Gelb, A. W.

ENVIRONMENTAL, EXERCISE AND RESPIRATORY PHYSIOLOGY

Cerebral blood flow during orthostasis: role of arterial CO2

J. M. Serrador,1 R. L. Hughson,2 J. M. Kowalchuk,3 R. L. Bondar,4 and A. W. Gelb5

1Division on Aging, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts; 2Department of Kinesiology, University of Waterloo, Waterloo, Ontario, Canada; 3Canadian Centre for Activity and Aging, School of Kinesiology, and Department of Physiology and Pharmacology, University of Western Ontario, London, Ontario, Canada; 4Sunnybrook and Women's Health Sciences Centre, Toronto, Ontario, Canada; and 5Department of Anaesthesia, University of California, San Francisco, San Francisco, California

Submitted 24 June 2005 ; accepted in final form 15 November 2005


   ABSTRACT
TOP
 ABSTRACT
METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Reductions in end-tidal PCO2 (PETCO2) during upright posture have been suggested to be the result of hyperventilation and the cause of decreases in cerebral blood flow (CBF). The goal of this study was to determine whether decreases in PETCO2 reflected decreases in arterial PCO2 (PaCO2) and their relation to increases in alveolar ventilation (VA) and decreases in CBF. Fifteen healthy subjects (10 women and 5 men) were subjected to a 10-min head-up tilt (HUT) protocol. PaCO2, VA, and cerebral flow velocity (CFV) in the middle and anterior cerebral arteries were examined. In 12 subjects who completed the protocol, reductions in PETCO2 and PaCO2 (–1.7 ± 0.5 and –1.1 ± 0.4 mmHg, P < 0.05) during minute 1 of HUT were associated with a significant increase in VA (+0.7 ± 0.3 l/min, P < 0.05). However, further decreases in PaCO2 (–0.5 ± 0.5 mmHg, P < 0.05), from minute 1 to the last minute of HUT, occurred even though VA did not change significantly (–0.2 ± 0.3 l/min, P = not significant). Similarly, CFV in the middle and anterior cerebral arteries decreased (–7 ± 2 and –8 ± 2%, P < 0.05) from minute 1 to the last minute of HUT, despite minimal changes in PaCO2. These data suggest that decreases in PETCO2 and PaCO2 during upright posture are not solely due to increased VA but could be due to ventilation-perfusion mismatch or a redistribution of CO2 stores. Furthermore, the reduction in PaCO2 did not fully explain the decrease in CFV throughout HUT. These data suggest that factors in addition to a reduction in PaCO2 play a role in the CBF response to orthostatic stress.

transcranial Doppler; cerebral vasoconstriction; head-up tilt

IT HAS BEEN WIDELY NOTED that orthostatic stress in humans decreases end-tidal PCO2 (PETCO2) or arterial PCO2 (PaCO2) (1, 4, 17, 27, 36, 38, 41). Because PaCO2 is known to be critical in control of cerebral blood flow (CBF) (30), decreased PaCO2 during tilt could play a role in orthostatic intolerance through inappropriate cerebral vasoconstriction. It has been hypothesized that hyperventilation in the upright posture reduces PaCO2, compromising CBF and leading to syncope (27).

One inherent problem with this previous work is the use of PETCO2 to represent PaCO2. Previous work has found that although, in the supine position, PETCO2 is closely matched to PaCO2 (i.e., ~0.8 mmHg greater), the assumption of the upright posture resulted in the PETCO2 being ~2.9 mmHg lower than PaCO2 (4).

No studies have directly measured alveolar ventilation (VA) and CBF during head-up tilt (HUT) and characterized their association to PaCO2. On the basis of our previous findings that decreases in PETCO2 did not relate to changes in minute ventilation (VE) (36), we hypothesized that PaCO2 decreases would be attenuated compared with PETCO2 and would not be the predominant factor in reduced CBF during HUT.


   METHODS
TOP
 ABSTRACT
 METHODS
RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Subjects. Fifteen subjects [10 women and 5 men, averaging 25.3 yr of age (range 21–32 yr), 64.3 ± 20.5 (SD) kg body wt, 174 ± 9 cm] with no history of cardiopulmonary, renal, or other systemic disease participated in the study. Caffeine, alcohol, and heavy exercise were prohibited for 24 h before testing. All subjects provided signed consent to the experimental protocols, which had been approved by the Ethics Review Board at the University of Western Ontario.

Tilt testing. After providing a medical history, the subjects were placed in the supine position. Under local anesthesia (0.5–1 ml lidocaine), a 22-gauge catheter was positioned within the radial artery of the nondominant arm to allow blood sampling. Heart rate was obtained via standard three-lead electrocardiogram (Hewlett Packard), and beat-by-beat blood pressures were obtained through a finger photoplethysmograph (Finapres) maintained at heart level.

Cerebral flow velocities (CFV) in the middle and anterior cerebral arteries (CFVMCA and CFVACA) were obtained with 2-MHz pulsed-wave transcranial Doppler (TCD) probes located over the temporal bones on each side (Medasonics CDS). For the MCA, the signal was range gated to a depth of 45–60 mm to ensure insonation of the M1 segment of the MCA according to standard techniques. For the ACA, gated depth was 60–75 mm. After the optimum signal was achieved, TCD probes were independently secured in place by headband devices.

Ventilatory data were collected via a face mask that allowed nasal and oral breathing. Expiratory and inspiratory gases (Random Access Mass Spectrometer, Marquette Electronics; Metabolic Cart, MedGraphics) and flow (ultrasonic flowmeter, Kou Consulting, Redmond, WA) were obtained throughout the collection period.

Subjects were supine throughout the instrumentation and stabilization period (55–65 min) and through 10 min of baseline data collection before they were passively tilted to an 85° upright position for 10 min or until the development of presyncopal symptoms. Previous research showed that ventilatory responses do not change between 5 and 20 min of tilt (1). Criteria for presyncope included any of the following: a sudden >25-mmHg drop of systolic pressure or >15-mmHg drop in diastolic pressure, a sudden and sustained >15-beat/min drop in heart rate, severe lightheadedness, and severe nausea or actual vomiting. After upright tilt, the subjects were returned to the supine position for a 10-min recovery period. Blood samples were drawn over 30-s periods during minutes 5, 7, and 9 of supine baseline; minutes 1, 2, 4, and 6, as well as the last minute, of HUT; and minutes 1, 4, and 9 of recovery.

Data analysis. The analog CFVMCA, CFVACA, heart rate, and blood pressure signals were sampled simultaneously at 10 kHz. VA was determined from the VA equation (VA = VCO2 * 0.863/PaCO2, where VCO2 is CO2 production), and physiological dead space was calculated from arterial and expired CO2 using the Bohr equation. Blood pressure at the level of the MCA and ACA was estimated by subtraction of the hydrostatic gradient from the heart to the level of the TCD probe (BPbrain). Estimates of an index of regional cerebrovascular resistance (CVR) were calculated for the MCA and ACA as follows: CVR = BPbrain/CFV. Because we assumed that intracranial pressure was unlikely to change greatly, BPbrain was used to reflect cerebral perfusion pressure (9). Previous work demonstrated that estimated CVR is a useful index of CVR in the upright posture (35). CFV was normalized to baseline (supine rest before HUT), because percent change has been shown to be the best reflection of changes in CBF (37). For comparison purposes, all beat-by-beat and breath-by-breath data were averaged over the 30-s periods in which blood samples were taken.

Statistics. To examine the role of PaCO2 in the cerebrovascular response to HUT, only subjects who were able to complete the 10-min HUT without developing presyncopal symptoms were included for analysis. The effects of HUT on ventilatory, cardiovascular, and cerebrovascular data were assessed using repeated-measures ANOVA with Bonferroni's post hoc analysis for multiple comparisons. Values were compared with baseline (mean of 3 supine values). Because our previous research demonstrated that CFV and PETCO2 continue to decrease in the upright posture (36, 38), a comparison of minute 1 with the last minute of HUT was performed. To examine the relation between VA, PaCO2, and CFV, correlations were obtained using Pearson's product-moment analysis. Values are means ± SE. P < 0.05 was considered significant.


   RESULTS
TOP
 ABSTRACT
 METHODS
 RESULTS
DISCUSSION
 GRANTS
 REFERENCES
 
Fifteen subjects participated in the study: 12 (8 women and 4 men) were able to complete the HUT protocol, and 3 (2 women and 1 man) developed presyncopal symptoms. We were unable to obtain ACA signals from two (orthostatically tolerant) subjects.

Ventilatory and blood gas responses. PETCO2 and PaCO2 were significantly reduced, whereas end-tidal PO2 was significantly increased throughout HUT (Fig. 1, Table 1). Although VE increased during HUT, VA was significantly elevated only in minute 1 of HUT (Fig. 1). The sustained increase in VE was due to an increase in physiological dead space (Table 1), inasmuch as tidal volume increased slightly (~10%) while breathing frequency did not change. Throughout HUT, there were no significant changes in O2 uptake (VO2) or VCO2 (Fig. 2). Consistent with this lack of change in VA and VCO2, VA/VCO2 did not change during HUT (Fig. 2). The small reductions in VO2 were sufficient to cause VA/VO2 to increase transiently during minutes 1 and 2 of HUT and then return to supine levels.


Figure 1
View larger version (28K):
[in this window]
[in a new window]
  		Fig. 1. Changes in end-tidal PCO2 (PETCO2), arterial PCO2 (PaCO2), expired ventilation (VE), alveolar ventilation (VA), blood pressure adjusted to brain level (BPbrain), and cerebral flow velocity (CFV) in middle and anterior cerebral arteries (CFVMCA and CFVACA) as well as cerebrovascular resistance (CVR) in the same vascular beds (CVRMCA and CVRACA) during head-up tilt (HUT). BASE, supine baseline; TILT, 85° HUT; RECOVERY, supine recovery. Values are means ± SE. Data (beat-by-beat or breath-by-breath) were obtained over 30-s periods in which arterial samples were drawn. VA was calculated from tidal volume, dead space (determined by the Bohr equation), and breathing frequency. *Significantly different from mean baseline values, P < 0.05. betaSignificantly different from minute 1 of HUT, P < 0.05.

 

View this table:
[in this window]
[in a new window]
  		Table 1. Ventilatory response to HUT

 

Figure 2
View larger version (26K):
[in this window]
[in a new window]
  		Fig. 2. Changes in CO2 production (VCO2), O2 uptake (VO2), VA/VCO2, and VA/VO2 during HUT. Values are means ± SE. *Significant different from mean baseline values, P < 0.05.

 
On return of the subjects to the supine position, there was a significant increase in VE and VA associated with an increase in PETCO2 to greater than baseline levels but with a sustained reduction in PaCO2 (Fig. 1). This increase in ventilation was due to a transient increase in tidal volume during minute 1 of recovery without an associated change in breathing frequency, and dead space returned to baseline values (Table 1). This increased ventilation was associated with a significant increase in VO2 and VCO2, as well as a decrease VA/VO2 (Fig. 2). VA/VCO2 remained unchanged.

Hemodynamic adjustments to HUT. HUT caused heart rate to increase significantly (Table 2) and BPbrain to decrease (Fig. 1) compared with the supine position. Heart rate and BPbrain returned to baseline levels during recovery, and heart rate was significantly below baseline during the last 5 min of recovery (Table 2). HUT caused a decrease in CFVMCA and CFVACA (Fig. 1). However, during minute 1 of HUT, only CFVACA decreased significantly.


View this table:
[in this window]
[in a new window]
  		Table 2. Circulatory response to HUT

 
Effect of prolonged orthostatic stress. After the initial decrease in CFV, there was a significant further decrease in CFVMCA (minutes 6–10) and CFVACA (minutes 4–10) during sustained HUT (Fig. 1). These decreases were associated with an increase in CVR in both vascular beds. Similarly, BPbrain increased after minute 1 of HUT.

To examine the effect of prolonged orthostatic stress, we examined the within-tilt (minutes 1–10 of HUT) response. After the initial decrease in CFV, there was a further significant decrease in CFVMCA and CFVACA within HUT (Fig. 3). This cerebral hypoperfusion during sustained HUT was associated with an increase in the CVR index for ACA and MCA. Similarly, HUT was associated with a further decrease in PETCO2 and PaCO2 (Fig. 3). Neither VE nor VA was significantly changed within HUT relative to the initial response.


Figure 3
View larger version (16K):
[in this window]
[in a new window]
  		Fig. 3. Within-tilt (i.e., difference between minutes 1 and 10 of tilt) PETCO2, PaCO2, VE, VA, BPbrain, CFVMCA, CFVACA, CVRMCA, and CVRACA responses. Values are means ± SE. *Significant change, P < 0.05.

 
Relation between ventilation, CO2, and CFV. Because it has been proposed that increases in VA decrease PaCO2, which in turn increases CVR and decreases CBF, we examined the relation among these variables within the 10 min of HUT. It did not appear that increases in VA considered in isolation could explain decreases in PaCO2 from minutes 1 to 10 of HUT, because VA actually decreased from minutes 1 to 10 of HUT (P = nonsignificant) and PaCO2 also decreased (Fig. 3).

We also examined the relation between changes in PaCO2 within tilt and CFV changes. To ensure that significant relations in individuals were not obscured by the averaging process, we examined the relations between changes in PaCO2 and CFV for each subject (Fig. 4). When we compared individual linear regressions with the expected change (3%/mmHg CO2) (18), it did not appear that changes in PaCO2 within tilt were producing the expected change in CFV for most subjects: MCA mean slope = 0.9 ± 0.7%/mmHg (r2 = 0.30 ± 0.07) and ACA mean slope = –0.6 ± 0.5%/mmHg (r2 = 0.32 ± 0.07). To ensure that this lack of correlation was not the result of a limited range of CO2 values, we performed linear regressions on breath-by-breath PETCO2 with the associated mean flow velocities for each breath comparing the change from the mean during minutes 10.25 to 10.75 of tilt (the same reference point at which the arterial sample was obtained). This analysis produced greater slopes [MCA = 1.7 ± 0.4%/mmHg (r2 = 0.16 ± 0.05) and ACA = 1.3 ± 0.4%/mmHg (r2 = 0.13 ± 0.05)]; however, they were still significantly lower than the expected ~3%/mmHg, suggesting that the reduced correlation was not due to limited data points.


Figure 4
View larger version (33K):
[in this window]
[in a new window]
  		Fig. 4. Left: change in PaCO2 during HUT and corresponding change in CFVMCA and CFVACA. All data points represent 30-s means during which arterial blood samples were drawn. Thin lines, individual regression lines for each subject; thick line, expected change in CFV for given change in PaCO2 on the basis of previous literature (18). Right: changes in PETCO2 during the same period of HUT. Data points represent individual breaths with associated mean flow velocities (different color for each subject). Thin lines, individual regression lines for each subject; thick line, expected change on the basis of previous data. Differences in slopes between left and right are likely due to changes in arterial-end-tidal gradient during upright posture, resulting in PETCO2 not as accurately reflecting PaCO2 (4).

 
Response of orthostatically intolerant subjects. Although the number of orthostatically intolerant subjects was insufficient for statistical analysis and comparison of the response with our orthostatically tolerant group, we have plotted the response of the three intolerant subjects (Fig. 5). These subjects demonstrated responses that were similar to those of our tolerant subjects. In all three subjects, an initial increase in VE (not shown) and VA was followed by a decrease to below baseline levels (2 of 3 subjects). Similarly, they demonstrated decreases in PETCO2 (not shown) and PaCO2. Although they showed a similar initial drop in BPbrain, their pressure continued to drop and was significantly lower than that of our tolerant group at the end of HUT. CFVMCA and CFVACA had similar temporal patterns but were significantly lower at the end of HUT. Interestingly, although all three subjects had typical presyncopal responses in pressure and flow (i.e., greatly reduced at presyncope), the proposed hyperventilation and hypocapnia were not consistently present. In two of the three subjects, VA was lower at presyncope than at baseline (+2.1, –1.4, and –1.1 l/min), and PaCO2 changes from baseline to presyncope were not consistent with severe hypocapnia (–6.1, –0.6, and –4.5 mmHg).


Figure 5
View larger version (26K):
[in this window]
[in a new window]
  		Fig. 5. Changes in PaCO2, VA, BPbrain, CFVMCA, and CFVACA during HUT. Values are means ± SE. END, last 30-s sample before the end of HUT. VA was calculated from tidal volume, dead space (determined by the Bohr equation), and breathing frequency.

 

   DISCUSSION
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
GRANTS
 REFERENCES
 
These data demonstrate three important findings: 1) postural hypocapnia was a common occurrence, 2) progressive decreases in CFV during HUT were due to increased CVR index, and 3) beyond minute 1 of tilt, there was no clear relation between changes in PaCO2 and CFV.

CFVMCA has been found to decrease with upright tilt (13, 17, 27, 38) and lower body negative pressure (LBNP) (6, 22). Concomitant with this decrease in CBF is a drop in PETCO2 (6, 17, 22, 27, 38). Because it is well known that a decrease in PaCO2 results in an increase in CVR (30), we investigated the possibility that the hypocapnia associated with orthostatic stress might be the cause of the cerebral hypoperfusion during 10 min of HUT.

Postural hypocapnia. Our observation of significant reductions in PETCO2 (–2.6 ± 0.6 mmHg) and PaCO2 (–1.6 ± 0.6 mmHg) during HUT is consistent with values reported previously (1, 4) during the development of postural hypocapnia. The decrease in PETCO2 in the upright posture has been attributed to hyperventilation (27), but the transient responses of ventilation and gas exchange with movement to the upright posture are complex. In minute 1 of HUT, the significant (~8%) increase in VA was associated with a significant increase in VA/VO2 but no change in VA/VCO2. The finding for VA/VO2 is consistent with a reduction in venous return with HUT (7, 23) that would also reduce total delivery of CO2 to the lungs. However, the small increase in VA together with the small, but nonsignificant, increase in VA/VCO2 indicates that some CO2 stores of the body were excreted in minute 1 of HUT, contributing to the reduction in PaCO2. Also supporting the idea that changes in whole body blood flow distribution might play a role in postural hypocapnia, Anthonisen and Milic-Emili (2) found that the decrease in PaCO2 did not occur when the tilt was performed while subjects were submerged in water to the xiphoid process to prevent venous pooling. Similarly, Gisolf et al. (12), using a theoretical model, demonstrated that decreases in cardiac output were responsible for ~20% of the decrease in PETCO2 during standing.

Beyond minute 1 of HUT, VCO2 did not change significantly. The very small (~4%) increase over baseline values was similar to previous reports of unchanged or slightly increased VCO2 during HUT (1, 4, 24–26, 43). The tendency for VA/VCO2 to be elevated throughout HUT is consistent with reports of increased VA for some (1, 4), but not all (4, 16), subjects. The significant increase in total VE above supine baseline was a consequence of increased dead space ventilation as observed previously (4), with no change in breathing frequency (3, 26).

Changes in total body CO2 stores with movement between supine and HUT positions also affects VCO2 through changes in PaCO2 and blood flow distribution (32) with a time course that could require up to 10 min to reach equilibrium (11). In our previous work, the drop in PETCO2 was shown to differ depending on the length of time the subjects are supine before tilt (36). Furthermore, maintaining ventilation did not eliminate the decrease in PETCO2 during LBNP (39), suggesting that mechanisms other than hyperventilation were involved.

Maintenance of lower levels of PaCO2 implies that the chemoreflex control of breathing was altered in the upright posture to a new set point. Indeed, recent evidence supports this idea through the observation of increased CO2 sensitivity in the upright posture (31).

Cerebrovascular response to the upright posture. Regardless of the mechanism, a decrease in PaCO2 should result in a decrease in CBF (30). Consistent with these findings, we found that, during HUT, CFVMCA and CFVACA were lower when PaCO2 and PETCO2 decreased (Fig. 1). However, examination of the temporal response during the tilt demonstrated a disparity between the changes in PaCO2 and CFV. Whereas PaCO2 had a large initial decrease and then slowly declined, CFV showed a progressive decrease (Fig. 1). Comparison of the change in PaCO2 and CFV during HUT on an individual basis showed no consistent trend. We did not see the expected ~3% decrease in CFV per mmHg decrease in PETCO2 (18). Similarly, if we examine the change in PETCO2 from minute 1 to the last minute of HUT, slopes were ~1.5%/mmHg, i.e., one-half of the expected values. Thus the role of PaCO2 in the decrease in CBF during orthostatic stress must be questioned.

Further questioning of the specific link between PaCO2 and CFV derives from our previous work in which we maintained PETCO2 at supine levels during upright tilts but did not eliminate the reduction in CBF (5). However, maintaining PETCO2 during 45° tilt did eliminate the decrease in CFV (10), indicating that a greater orthostatic stress was required to elicit a tilt-related decrease in CFV unrelated to postural hypocapnia.

If reductions in PaCO2 do not explain the progressive fall in CFVMCA and CFVACA during HUT, other mechanisms must be examined. The concurrent increase in CVR indicates that the time-dependent fall in CFV was due to cerebral vasoconstriction.

Although part of this constrictive response might have been the result of an appropriate autoregulatory response to the ~6% increase in BPbrain during tilt, it seems unlikely that autoregulation would reduce CFV under conditions where BPbrain was ~20 mmHg lower than in the supine posture. Altered cerebrovascular control unrelated to changes in PETCO2 has been reported during LBNP following bed rest (44) and parabolic flight (38). In addition, a paradoxical cerebral vasoconstriction in healthy (5, 6, 22, 38) and orthostatically intolerant (13, 14) individuals has been reported during postural stress and LBNP. However, our previous work (38), as well as that of others (8, 21), showed that cerebral autoregulation remains intact during HUT in healthy subjects, suggesting that decreases in perfusion pressure were unlikely to be the cause of the decrease in cerebral flow. Similarly, analysis of transfer function gain between CFV and blood pressure found no change in gains during tilt in these subjects (data not shown). Other possible causes may be increased sympathetic outflow to the brain (34), activation of vestibular or other central mechanisms (38, 42), endocrine-related changes such as angiotensin (33), changes in cardiac output (41), or as yet undetermined mechanisms.

The role of PaCO2 or cerebral vasoconstriction in the development of orthostatic intolerance is poorly understood. Previous research has suggested a role for PaCO2 (27) and cerebral vasoconstriction (13). In the three subjects who became presyncopal in this study, only two demonstrated significant decreases in PaCO2 (Fig. 5). Even in these subjects, decreases in CFV at the end of HUT were again approximately double that predicted from changes in PaCO2. Consistent with this minimal role for PaCO2 in the development of syncope in healthy individuals, in previous work, voluntary hyperventilation during supine LBNP was found to produce significant hypocapnia, dramatic reductions in CFVMCA, and large increases in CVR without concurrent hypotension or syncope (22). Similarly, we previously found that addition of inspired CO2 extends the time to presyncope but does not prevent it (5). These data suggest that although postural hypocapnia may contribute to cerebral hypoperfusion, it does not appear to be a primary cause of orthostatic intolerance.

Interestingly, several previous studies noted a frontal cerebral hypoperfusion in patients and subjects who become orthostatically intolerant (15, 28, 29, 40). Similarly, we found greater decreases in CFVACA than in CFVMCA during HUT, although they were not significant (P = 0.056). However, this was not the case in the three subjects who became presyncopal in this study, because they demonstrated significantly reduced end-tilt CFVMCA (70.6 ± 6.3%) and CFVACA (71.9 ± 8.3%) without a relative frontal hypoperfusion (i.e., greater reduction in CFVACA). However, because only three subjects became presyncopal, it is possible that a larger number would have shown a frontal cerebral hypoperfusion.

Limitations. It must be considered that the relation between ventilation, hypocapnia, and cerebrovascular tone during HUT is different between healthy volunteers, as studied in the present and previous experiments (22, 38), and patients who are chronically orthostatically intolerant (27). Also we must consider that blood samples were drawn over 30-s periods. Because presyncopal symptoms may appear rapidly, it is possible that an increase in VA in the last 15 s of HUT was not detected. However, examination of VE on a breath-by-breath basis during the same period did not demonstrate a discordant increase.

A primary limitation of TCD evaluations is the assumption that MCA diameter at the point of insonation is not changing. In a recent examination of this issue, Serrador et al. (37) used MRI measures of MCA diameter combined with TCD measures of CFV during LBNP and various levels of PETCO2. Although CFV changed considerably in response to the experimental manipulations, no change in MCA diameter at the M1 segment was found. Other work examined the lower limit of cerebral autoregulation using a combination of ganglionic blockade and LBNP to create hypotension. These studies found significant correlations between CBF (using 133Xe) and mean flow velocity: r2 = 0.60 (19) and r2 = 0.73 (20).

Finally, to estimate CVR, we must assume that intracranial pressure changes are minimal. Recently, Dawson et al. (9) found that internal jugular venous pressure decreased from ~10 to ~5 mmHg in the transition from the supine to the seated position. If intracranial pressure were to decrease ~5 mmHg throughout tilt, the increase in CVR would be ~5% greater, suggesting that we underestimated the increase in CVR. To minimize the possible effect of increased pulsatility in finger measures of blood pressure, mean pressure was used to calculate CVR (35).

The present study has documented development of postural hypocapnia through reductions in PaCO2 and PETCO2 during HUT. We have shown, however, a dissociation between the fall in PaCO2 and the decline in cerebral mean flow velocity. These observations suggest that other mechanisms, in addition to the decline in PaCO2, are responsible for the increase in CVR and the reduction in cerebral flow during HUT.


   GRANTS
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
REFERENCES
 
This research was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), the Medical Research Council of Canada, the Canadian Space Agency, and Heart and Stroke Foundation of Ontario Grant T4972. J. M. Serrador was supported by an NSERC Postgraduate Scholarship.


   ACKNOWLEDGMENTS
 
The authors are grateful to Dr. Andrew Wyss, Dr. Barry Scheurerman, Dr. Tim Wilson, Anne Powell, and Dave Northey for assistance with data collection. The authors thank Dr. Kevin Shoemaker and Dr. Brian Hunt for helpful comments on this manuscript.


   FOOTNOTES
 

Address for reprint requests and other correspondence: J. M Serrador, Harvard Medical School, Beth Israel Deaconess Medical Center, One Deaconess Rd., Palmer 117, Boston, MA 02215 (e-mail: serrador{at}hms.harvard.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Anthonisen NR, Bartlett JR, and Tenney SM. Postural effect on ventilatory control. J Appl Physiol 20: 191–196, 1965.[Abstract/Free Full Text]
  2. Anthonisen NR and Milic-Emili J. Distribution of pulmonary perfusion in erect man. J Appl Physiol 21: 760–766, 1966.[Free Full Text]
  3. Barrett J, Cerny F, Hirsch JA, and Bishop B. Control of breathing patterns and abdominal muscles during graded loads and tilt. J Appl Physiol 76: 2473–2480, 1994.[Abstract/Free Full Text]
  4. Bjurstedt H, Hesser CM, Liljestrand G, and Matell G. Effects of posture on alveolar-arterial CO2 and O2 differences and on alveolar dead space in man. Acta Physiol Scand 54: 65–82, 1962.[ISI][Medline]
  5. Blaber AP, Bondar RL, Moradshahi P, Serrador JM, and Hughson RL. Inspiratory CO2 increases orthostatic tolerance during repeated tilt. Aviat Space Environ Med 72: 985–991, 2001.[Medline]
  6. Bondar RL, Kassam MS, Stein F, Dunphy PT, Fortney S, and Riedesel ML. Simultaneous cerebrovascular and cardiovascular responses during presyncope. Stroke 26: 1794–1800, 1995.[Abstract/Free Full Text]
  7. Butler GC, Yamamoto Y, Xing HC, Northey DR, and Hughson RL. Heart rate variability and fractal dimension during orthostatic challenges. J Appl Physiol 75: 2602–2612, 1993.[Abstract/Free Full Text]
  8. Carey BJ, Manktelow BN, Panerai RB, and Potter JF. Cerebral autoregulatory responses to head-up tilt in normal subjects and patients with recurrent vasovagal syncope. Circulation 104: 898–902, 2001.[Abstract/Free Full Text]
  9. Dawson EA, Secher NH, Dalsgaard MK, Ogoh S, Yoshiga CC, Gonzalez-Alonso J, Steensberg A, and Raven PB. Standing up to the challenge of standing: a siphon does not support cerebral blood flow in humans. Am J Physiol Regul Integr Comp Physiol 287: R911–R914, 2004.[Abstract/Free Full Text]
  10. Edwards MR, Shoemaker JK, and Hughson RL. Dynamic modulation of cerebrovascular resistance as an index of autoregulation under tilt and controlled PETCO2. Am J Physiol Regul Integr Comp Physiol 283: R653–R662, 2002.[Abstract/Free Full Text]
  11. Farhi LE and Rahn H. Dynamics of changes in carbon dioxide stores. Anesthesiology 21: 604–614, 1960.[ISI][Medline]
  12. Gisolf J, Wilders R, Immink RV, van Lieshout JJ, and Karemaker JM. Tidal volume, cardiac output and functional residual capacity determine end-tidal CO2 transient during standing up in humans. J Physiol 554: 579–590, 2004.[Abstract/Free Full Text]
  13. Grubb BP, Gerard G, Roush K, Temesy-Armos P, Montford P, Elliott L, Hahn H, and Brewster P. Cerebral vasoconstriction during head-upright tilt-induced vasovagal syncope. A paradoxic and unexpected response. Circulation 84: 1157–1164, 1991.[Abstract/Free Full Text]
  14. Grubb BP, Samoil D, Kosinski D, Wolfe D, Brewster P, Elliott L, and Hahn H. Cerebral syncope: loss of consciousness associated with cerebral vasoconstriction in the absence of systemic hypotension. Pacing Clin Electrophysiol 21: 652–658, 1998.[CrossRef][Medline]
  15. Hayashida K, Nishiooeda Y, Hirose Y, Ishida Y, and Nishimura T. Maladaptation of vascular response in frontal area of patients with orthostatic hypotension. J Nucl Med 37: 1–4, 1996.[Abstract/Free Full Text]
  16. Hughes JM. Regional lung function: physiology and clinical applications. Clin Physiol 5: 19–31, 1985.[Medline]
  17. Hughson RL, Edwards MR, O'Leary DD, and Shoemaker JK. Critical analysis of cerebrovascular autoregulation during repeated head-up tilt. Stroke 32: 2403–2408, 2001.[Abstract/Free Full Text]
  18. Ide K, Eliasziw M, and Poulin MJ. Relationship between middle cerebral artery blood velocity and end-tidal PCO2 in the hypocapnic-hypercapnic range in humans. J Appl Physiol 95: 129–137, 2003.[Abstract/Free Full Text]
  19. Larsen FS, Olsen KS, Ejlersen E, Hansen BA, Paulson OB, and Knudsen GM. Cerebral blood flow autoregulation and transcranial Doppler sonography in patients with cirrhosis. Hepatology 22: 730–736, 1995.[CrossRef][ISI][Medline]
  20. Larsen FS, Olsen KS, Hansen BA, Paulson OB, and Knudsen GM. Transcranial Doppler is valid for determination of the lower limit of cerebral blood flow autoregulation. Stroke 25: 1985–1988, 1994.[Abstract]
  21. Leftheriotis G, Preckel MP, Fizanne L, Victor J, Dupuis JM, and Saumet JL. Effect of head-upright tilt on the dynamic of cerebral autoregulation. Clin Physiol 18: 41–47, 1998.[CrossRef][ISI][Medline]
  22. Levine BD, Giller CA, Lane LD, Buckey JC, and Blomqvist CG. Cerebral versus systemic hemodynamics during graded orthostatic stress in humans. Circulation 90: 298–306, 1994.[Abstract/Free Full Text]
  23. Levine BD, Pawelczyk JA, Ertl AC, Cox JF, Zuckerman JH, Diedrich A, Biaggioni I, Ray CA, Smith ML, Iwase S, Saito M, Sugiyama Y, Mano T, Zhang R, Iwasaki K, Lane LD, Buckey JC Jr, Cooke WH, Baisch FJ, Eckberg DL, and Blomqvist CG. Human muscle sympathetic neural and haemodynamic responses to tilt following spaceflight. J Physiol 538: 331–340, 2002.[Abstract/Free Full Text]
  24. Loeppky JA and Luft UC. Fluctuations in O2 stores and gas exchange with passive changes in posture. J Appl Physiol 39: 47–53, 1975.[Abstract/Free Full Text]
  25. Matalon SV and Farhi LE. Cardiopulmonary readjustments in passive tilt. J Appl Physiol 47: 503–507, 1979.[Abstract/Free Full Text]
  26. Miyamoto Y, Tamura T, Hiura T, Nakamura T, Higuchi J, and Mikami T. The dynamic response of the cardiopulmonary parameters to passive head-up tilt. Jpn J Physiol 32: 245–258, 1982.[ISI][Medline]
  27. Novak V, Spies JM, Novak P, McPhee BR, Rummans TA, and Low PA. Hypocapnia and cerebral hypoperfusion in orthostatic intolerance. Stroke 29: 1876–1881, 1998.[Abstract/Free Full Text]
  28. Odano I, Takahashi N, Higuchi T, Ohkubo M, Hama S, Tsuda A, Otaki H, Noguchi E, and Hatano M. Evaluation of cerebral blood flow in patients with idiopathic orthostatic hypotension using Tc-99m HMPAO brain SPECT during postural testing. Clin Nucl Med 20: 807–809, 1995.[ISI][Medline]
  29. Passant U, Warkentin S, Minthon L, Faldt R, and Edvinsson L. Cortical blood flow during head-up postural change in subjects with orthostatic hypotension. Clin Auton Res 3: 311–318, 1993.[CrossRef][Medline]
  30. Paulson OB, Strandgaard S, and Edvinsson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev 2: 161–192, 1990.[ISI][Medline]
  31. Richardson L, Topor Z, Bhakta D, McCaffrey F, Bruce E, and Patwardhan A. Assessment of ventilatory sensitivity to carbon dioxide changes during orthostasis. Biomed Sci Instrum 38: 301–305, 2002.[Medline]
  32. Rowell LB. Human Cardiovascular Control. New York: Oxford University Press, 1993.
  33. Saavedra JM and Nishimura Y. Angiotensin and cerebral blood flow. Cell Mol Neurobiol 19: 553–573, 1999.[CrossRef][ISI][Medline]
  34. Sandor P. Nervous control of the cerebrovascular system: doubts and facts. Neurochem Int 35: 237–259, 1999.[CrossRef][ISI][Medline]
  35. Schondorf R, Benoit J, and Wein T. Cerebrovascular and cardiovascular measurements during neurally mediated syncope induced by head-up tilt. Stroke 28: 1564–1568, 1997.[Abstract/Free Full Text]
  36. Serrador JM, Bondar RL, and Hughson RL. Ventilatory response to passive head up tilt. In: Advances in Modeling and Control of Ventilation, edited by Hughson RL, Cunningham DA, and Duffin J. New York: Plenum, 1998, p. 133–139.
  37. Serrador JM, Picot PA, Rutt BK, Shoemaker JK, and Bondar RL. MRI measures of middle cerebral artery diameter in conscious humans during simulated orthostasis. Stroke 31: 1672–1678, 2000.[Abstract/Free Full Text]
  38. Serrador JM, Shoemaker JK, Brown TE, Kassam MS, Bondar RL, and Schlegel TT. Cerebral vasoconstriction precedes orthostatic intolerance after parabolic flight. Brain Res Bull 53: 113–120, 2000.[CrossRef][ISI][Medline]
  39. Taylor JA, Halliwill JR, Brown TE, Hayano J, and Eckberg DL. "Non-hypotensive" hypovolaemia reduces ascending aortic dimensions in humans. J Physiol 483: 289–298, 1995.[Abstract/Free Full Text]
  40. Toyry JP, Kuikka JT, and Lansimies EA. Regional cerebral perfusion in cardiovascular reflex syncope. Eur J Nucl Med 24: 215–218, 1997.[CrossRef][ISI][Medline]
  41. Van Lieshout JJ, Pott F, Madsen PL, van Goudoever J, and Secher NH. Muscle tensing during standing: effects on cerebral tissue oxygenation and cerebral artery blood velocity. Stroke 32: 1546–1551, 2001.[Abstract/Free Full Text]
  42. Wilson TD, Serrador JM, and Shoemaker JK. Head position modifies cerebrovascular response to orthostatic stress. Brain Res 961: 261–268, 2003.[CrossRef][ISI][Medline]
  43. Yoshizaki H, Yoshida A, Hayashi F, and Fukuda Y. Effect of posture change on control of ventilation. Jpn J Physiol 48: 267–273, 1998.[CrossRef][ISI][Medline]
  44. Zhang R, Zuckerman JH, Pawelczyk JA, and Levine BD. Effects of head-down-tilt bed rest on cerebral hemodynamics during orthostatic stress. J Appl Physiol 83: 2139–2145, 1997.[Abstract/Free Full Text]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/4/R1087    most recent
00446.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Serrador, J. M.
Right arrow Articles by Gelb, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Serrador, J. M.
Right arrow Articles by Gelb, A. W.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.